BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 32107624)

  • 1. Precise therapeutic effect of self-assembling gold nanocluster-PTEN complexes on an orthotropic model of liver cancer.
    Wang M; Wang L; Feng H; Jiang H; Zhou J; Wang X
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):875-882. PubMed ID: 32107624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ self-assembling Au-DNA complexes for targeted cancer bioimaging and inhibition.
    Wang M; Chen Y; Cai W; Feng H; Du T; Liu W; Jiang H; Pasquarelli A; Weizmann Y; Wang X
    Proc Natl Acad Sci U S A; 2020 Jan; 117(1):308-316. PubMed ID: 31843938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrazinocurcumin and 5-fluorouracil enhance apoptosis and restrain tumorigenicity of HepG2 cells via disrupting the PTEN-mediated PI3K/Akt signaling pathway.
    Zhou Y; Zhang M; Zhang Z; Jia Y; Zhang C; Peng L
    Biomed Pharmacother; 2020 Sep; 129():109851. PubMed ID: 32559627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of PTEN in athymic mice with HCC treated by complex prescription of Chinese crude drug].
    Sun BG; Chen ZX; Zhang SJ; Liu YD; Huang HZ; Yin LR
    Zhongguo Zhong Yao Za Zhi; 2007 Jun; 32(11):1057-60. PubMed ID: 17672343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamer-mediated gene therapy enhanced antitumor activity against human hepatocellular carcinoma in vitro and in vivo.
    Xiao S; Liu Z; Deng R; Li C; Fu S; Chen G; Zhang X; Ke F; Ke S; Yu X; Wang S; Zhong Z
    J Control Release; 2017 Jul; 258():130-145. PubMed ID: 28522194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
    Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin Prodrug-Conjugated Gold Nanocluster for Fluorescence Imaging and Targeted Therapy of the Breast Cancer.
    Zhou F; Feng B; Yu H; Wang D; Wang T; Liu J; Meng Q; Wang S; Zhang P; Zhang Z; Li Y
    Theranostics; 2016; 6(5):679-87. PubMed ID: 27022415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma.
    Xue HY; Liu Y; Liao JZ; Lin JS; Li B; Yuan WG; Lee RJ; Li L; Xu CR; He XX
    Oncotarget; 2016 Dec; 7(52):86675-86686. PubMed ID: 27880727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver cancer cells are sensitive to Lanatoside C induced cell death independent of their PTEN status.
    Durmaz I; Guven EB; Ersahin T; Ozturk M; Calis I; Cetin-Atalay R
    Phytomedicine; 2016 Jan; 23(1):42-51. PubMed ID: 26902406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN/PI3K/Akt/Bad signaling pathway.
    Feng X; Jiang J; Shi S; Xie H; Zhou L; Zheng S
    Int J Oncol; 2016 Dec; 49(6):2600-2610. PubMed ID: 27840896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma.
    Cai L; Li J; Zhang X; Lu Y; Wang J; Lyu X; Chen Y; Liu J; Cai H; Wang Y; Li X
    Oncotarget; 2015 Apr; 6(10):7838-50. PubMed ID: 25691053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of PTEN, p27, p21 and AKT mRNA and protein in human BEL-7402 hepatocarcinoma cells in transplanted tumors of nude mice treated with the tripeptide tyroservatide (YSV).
    Zhu Z; Jia J; Lu R; Lu Y; Fu Z; Zhao L; Wang L; Jin M; Zhao L; Gao W; Yao Z
    Int J Cancer; 2006 Mar; 118(6):1539-44. PubMed ID: 16184552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis.
    Li JJ; Yin HK; Guan DX; Zhao JS; Feng YX; Deng YZ; Wang X; Li N; Wang XF; Cheng SQ; Bao Y; Xie D
    Br J Cancer; 2018 May; 118(10):1337-1348. PubMed ID: 29717200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrine derivative WM130 inhibits hepatocellular carcinoma by suppressing EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways.
    Qian L; Liu Y; Xu Y; Ji W; Wu Q; Liu Y; Gao Q; Su C
    Cancer Lett; 2015 Nov; 368(1):126-134. PubMed ID: 26259512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental Study on the Effect of a Weifufang on Human Gastric Adenocarcinoma Cell Line BGC-823 Xenografts and
    He JQ; Zhang SR; Li DF; Tang JY; Wang YQ; He X; Li YM; Wu H; Zhou M; Jiao J; Xiao PL
    Cancer Biother Radiopharm; 2020 Apr; 35(3):199-207. PubMed ID: 31976763
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination of active targeting, enzyme-triggered release and fluorescent dye into gold nanoclusters for endomicroscopy-guided photothermal/photodynamic therapy to pancreatic ductal adenocarcinoma.
    Li H; Wang P; Deng Y; Zeng M; Tang Y; Zhu WH; Cheng Y
    Biomaterials; 2017 Sep; 139():30-38. PubMed ID: 28582716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative biokinetics and systemic translocation of various gold nanostructures are highly dependent on their size and shape.
    Zhang J; Nie X; Ji Y; Liu Y; Wu X; Chen C; Fang X
    J Nanosci Nanotechnol; 2014 Jun; 14(6):4124-38. PubMed ID: 24738361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.
    Li WX; Chen LP; Sun MY; Li JT; Liu HZ; Zhu W
    Oncotarget; 2015 Sep; 6(27):23776-92. PubMed ID: 26068982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.